Real-World Experience of Adalimumab in the Treatment of Hidradenitis Suppurativa
Published: 7 December 2020| Version 1 | DOI: 10.17632/pfz95dbvgm.1
Contributors:
,
,
,
,
Description
Supplemental Data on Reasons for Adalimumab Treatment Discontinuation and Secondary Treatment Initiated After Adalimumab Treatment Failure
Files
Institutions
University of Pittsburgh Medical Center
Categories
Hidradenitis Suppurativa